asa glp 1 guidelines GLP-1 RA guidance roundup Impact of GLP-1 Receptor Agonists
Description
Next-generation pain-free injection Nano-microneedle joint patch
Journal reference: Abbasi et al
Described as a disorder of glucose homeostasis and insulin sensitivity, it is primarily triggered by uncontrolled hyperglycemia, and it is responsible for a large number of microvascular (like diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy) and macrovascular complications (like diabetic foot syndrome, cerebrovascular events, and myocardial infarction) [5]
Includes: Slim Trim Appetite Suppressant Patch
Practice Point 4.3.3: GLP-1 RA should not be used in combination with DPP-4 inhibitors
